Dr. James Goldenberg
Dr. James Goldenberg
Dr. Goldenberg was born in New York in 1962. He soon moved to Florida and has been here ever since. His undergraduate degree is in Psychology from the University of Florida. His Medical School degree is from the University of South Florida. His residency in Neurology was at the University of Miami followed by a Fellowship in Neuromuscular Diseases and EMG. Dr. Goldenberg is Board Certified and has been in practice in central Palm Beach County since 1994..
learn more »

Dr. EricKramer Dr. Eric Kramer
Dr. Kramer obtained his undergraduate degree in Psychology from Glassboro State College. From there he went on to Temple University to obtain his Medical degree and postgraduate degree in Neurology. His neurology residency was completed at the Pennsylvania Hospital and his subsequent fellowship in the sub-specialized field of Neuro-oncology at the Children’s Hospital, of Philadelphia and the University of Pennsylvania...
learn more »

Dr. Mark Goldstein

Dr. Mark Goldstein
Dr. Goldstein obtained his undergraduate degree at Colgate University before attending Emory University from where he received his MD degree. He did a three year internal medicine residency at the Robert Woods Johnson School of Medicine and completed his neurology training at Stanford University in Palo Alto, CA. He is Board Certified in both Internal Medicine and Neurology...
learn more »


Staff Training

All physicians and research staff are continually expanding their knowledge base in our industry.  Continuing education is encouraged within our organization.  In addition to the sponsor-required GCP and protocol-specific training, the staff continues to train through other well established organizations (ACRP, CITI, FDA).

We have had the pleasure of working with numerous pharmaceutical companies since our inception.  We continue to expand our relationships and hope that we may add to our already extensive list.

• Pfizer
• Wyeth Pharmaceuticals
• Janssen AI
• Sunovion Pharmaceuticals (formally Sepracor)
• Novartis Pharmaceuticals
• Schering-Plough
• Merck Pharmaceuticals
• Elan Pharmaceuticals
• Abbott Pharmaceuticals
• Neuromed
• Schwarz Pharma
• Sangamo Biosciences

Our therapeutic areas include, but are not limited to

• Alzheimer’s disease
• Parkinson’s disease
• Post-Herpetic Neuralgia
• Multiple Sclerosis
• Low Back Pain
• Osteoarthritis
• Epilepsy
• Depression
• Diabetic Peripheral Neuropathy
Clinical Research Fact:
The average number of participants needed for a new drug trial jumped from 2,270 participants in the 1980s to 3,700 participants in the 1990s. (Food & Drug Administration)


130 JFK Drive, Suite 203
Atlantis, FL 33462


Copyright 2017 © JEM Research
Institute Atlantis, FL
Websites by Jupiter Website Design

About Us

Industry Contact

About Us

Learn About Clinical Trials
Current Clinical Trials
Guest Contact




U.S. Department of Health & Human Services
National Institutes of Health